You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國生物製藥(01177.HK):腦神經保護劑“依達拉奉氯化鈉注射液”獲藥品註冊批件
格隆匯 01-14 12:06

格隆匯1月14日丨中國生物製藥(01177.HK)宣佈,由公司附屬公司江蘇正大豐海製藥有限公司開發的腦神經保護劑“依達拉奉氯化鈉注射液”(商品名稱:依必坦),已獲中華人民共和國國家藥品監督管理局頒發藥品註冊批件。該產品為國內唯一獲批的100ml注射液規格,以化藥新3類註冊獲批,被視同通過(且為獨家劑型獲通過)仿製藥質量和療效一致性評價。

依達拉奉是臨牀有效的腦神經保護劑,能減輕腦細胞受損,保護組織功能,主要用於改善急性腦梗塞所致的神經症狀、日常生活活動能力和功能障礙,為神經內科、神經外科、急診等科室使用。依達拉奉被《中國急性缺血性腦卒中診治指南》、《中國腦出血診治指南》等多個權威指南推薦,可有效改善急性腦梗死、腦出血等患者的神經功能損傷。

集團將不斷加快新品開發以豐富產品線,繼續加強在圍手術期各個治療領域的拓展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account